Molecular Biology

分子生物学

基本信息

项目摘要

PROJECT SUMMARY The Molecular Biology (MB) Core has been created to meet the need for advanced molecular biology support by PJIs. In particular, access to and experience in utilizing advanced molecular biology that are limited for most PJIs and established NIH-funded investigators. Specifically, MB Core will leverage and expand the resources and expertise of the Genelab Core facility which is comprised of three existing Core Facilities operated by the Division of Biotechnology and Molecular Medicine (BioMMED) at the LSU School of Veterinary Medicine (SVM): Gene expression and sequencing Laboratory (GeneLab), Protein characterization and purification laboratory (PCPL), which is also responsible for generation of monospecific antibodies to proteins of interest, and the Molecular Immunopathology laboratory (MIPL) that provides expertise and access to bioimaging and advanced immunofluorescence and electron microscopy. These three laboratories are currently co-supported by the NIGMS-funded CEIDR-COBRE (Phase III) as well as the Louisiana Biomedical Research Network (LBRN/INBRE). The goal of the MB Core Facility of the Lung COBRE is to provide high quality instrumentation, sample preparation and training in a broad spectrum of fundamental and advanced molecular biology techniques to all COBRE PJIs and other NIH-funded investigators to achieve their research objectives. The MB Core has established 2 specific aims. Aim 1 is to provide the COBRE and other NIH-funded investigators with resources and expertise in molecular and cell biology, including instrumentation, technical support, consultation, and training. Aim 2 is to organize, coordinate, and facilitate interactions among COBRE investigators, mentors, and students, promote the development and use of new technologies and assays, and train PJI faculty, staff, and students in advanced molecular biology technologies.
项目摘要 分子生物学(MB)核心已经创建,以满足先进的分子生物学支持的需要 在PJI。特别是,获得和利用先进的分子生物学的经验是有限的, PJIs和NIH资助的研究人员。具体而言,MB Core将利用和扩展资源 Genelab核心设施由三个现有的核心设施组成, 生物技术和分子医学部(BioMMED),路易斯安那州立大学兽医学院 (SVM):基因表达和测序实验室(GeneLab),蛋白质表征和纯化 实验室(PCPL),其也负责产生针对感兴趣蛋白的单特异性抗体, 和分子免疫病理学实验室(MIPL),提供专业知识和生物成像, 先进的免疫荧光和电子显微镜。这三个实验室目前共同支持 由NIGMS资助的CEIDR-COBRE(第三阶段)以及路易斯安那州生物医学研究网络 (LBRN/INBRE)。肺COBRE的MB核心设施的目标是提供高质量的仪器, 在基础和先进的分子生物学的广泛的样品制备和培训 所有COBRE PJIs和其他NIH资助的研究人员都可以使用这些技术来实现他们的研究目标。的MB 核心设定了两个具体目标。目标1是为COBRE和其他NIH资助的研究人员提供 分子和细胞生物学方面的资源和专业知识,包括仪器,技术支持, 咨询和培训。目标2是组织、协调和促进COBRE之间的互动 研究人员、导师和学生,促进新技术和分析的开发和使用,以及 对PJI教职员工和学生进行先进分子生物学技术培训。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Konstantin G Kousoulas其他文献

Hyperthermia-Mediated Cell Death in Murine GT1-7 Hypothalamic Neurons and Human LnCap Prostate Carcinoma Cells Exposed to Nanoparticles of SPIONs@Au-Cysteamine-LHRH
  • DOI:
    10.1016/j.freeradbiomed.2010.10.180
  • 发表时间:
    2010-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Faruq Mohammad;Sainath Babu;Achuthan C Raghavamenon;Kumar SSR Challa;Konstantin G Kousoulas;Rao M Uppu
  • 通讯作者:
    Rao M Uppu

Konstantin G Kousoulas的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Konstantin G Kousoulas', 18)}}的其他基金

National IDeA Symposium of Biomedical Research Excellence - NISBRE
全国 IDeA 生物医学研究卓越研讨会 - NISBRE
  • 批准号:
    10318869
  • 财政年份:
    2022
  • 资助金额:
    $ 25.82万
  • 项目类别:
Molecular Biology and Immunopathology Core
分子生物学和免疫病理学核心
  • 批准号:
    10579207
  • 财政年份:
    2021
  • 资助金额:
    $ 25.82万
  • 项目类别:
Molecular Biology and Immunopathology Core
分子生物学和免疫病理学核心
  • 批准号:
    10360594
  • 财政年份:
    2021
  • 资助金额:
    $ 25.82万
  • 项目类别:
Molecular Biology
分子生物学
  • 批准号:
    10341064
  • 财政年份:
    2019
  • 资助金额:
    $ 25.82万
  • 项目类别:
Molecular Biology
分子生物学
  • 批准号:
    10078637
  • 财政年份:
    2019
  • 资助金额:
    $ 25.82万
  • 项目类别:
Characterization of Protective Immunity to MTB in a Setting of HIV Coinfection
HIV 合并感染情况下 MTB 保护性免疫的特征
  • 批准号:
    9302690
  • 财政年份:
    2016
  • 资助金额:
    $ 25.82万
  • 项目类别:
Correlates of protection from TB and TB/AIDS comorbidity
预防结核病和结核病/艾滋病合并症的相关性
  • 批准号:
    9302257
  • 财政年份:
    2016
  • 资助金额:
    $ 25.82万
  • 项目类别:
Pilot Grants Program
试点资助计划
  • 批准号:
    8751078
  • 财政年份:
    2014
  • 资助金额:
    $ 25.82万
  • 项目类别:
Center for Experimental Infectious Disease Research
实验传染病研究中心
  • 批准号:
    8857508
  • 财政年份:
    2014
  • 资助金额:
    $ 25.82万
  • 项目类别:
Center for Experimental Infectious Disease Research
实验传染病研究中心
  • 批准号:
    8711688
  • 财政年份:
    2014
  • 资助金额:
    $ 25.82万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 25.82万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.82万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 25.82万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.82万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 25.82万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 25.82万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.82万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 25.82万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 25.82万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.82万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了